KLRB1 and neuroblastoma: These data were sufficient to identify somatic genetic alterations accounting for NB tumour aggression including the loss of KLRB1, MAPK3 and FANCA at the time of progression from 4S to 4, a determinantal switch in the patient’s prognosis [56].